Search for other papers by Xiaobing Lu in
Google Scholar
PubMed
Search for other papers by Jiang Yue in
Google Scholar
PubMed
Search for other papers by Qianjing Liu in
Google Scholar
PubMed
Search for other papers by Shengyun He in
Google Scholar
PubMed
Search for other papers by Ying Dong in
Google Scholar
PubMed
Search for other papers by Ming Zhang in
Google Scholar
PubMed
Search for other papers by Yicheng Qi in
Google Scholar
PubMed
Search for other papers by Minglan Yang in
Google Scholar
PubMed
Search for other papers by Wang Zhang in
Google Scholar
PubMed
Search for other papers by Hua Xu in
Google Scholar
PubMed
Search for other papers by Qing Lu in
Google Scholar
PubMed
Search for other papers by Jing Ma in
Google Scholar
PubMed
Introduction Obesity has become one of the greatest public health challenges nowadays. It is estimated that more than 50% of adults worldwide will be overweight or obese by 2030 ( 1 ). In China, the prevalence of overweight/obesity in adults
Search for other papers by Anouar Aznou in
Google Scholar
PubMed
Search for other papers by Rick Meijer in
Google Scholar
PubMed
Search for other papers by Daniel van Raalte in
Google Scholar
PubMed
Search for other papers by Martin den Heijer in
Google Scholar
PubMed
Search for other papers by Annemieke Heijboer in
Google Scholar
PubMed
Search for other papers by Renate de Jongh in
Google Scholar
PubMed
obese children and adolescents ( 10 ) have been described. These studies are, however, inconsistent in the presence and the direction of the association ( 11 ). Adipose tissue appears to be involved in the association between Wnt signalling and insulin
Search for other papers by Jay Toulany in
Google Scholar
PubMed
Search for other papers by Sebastian D Parlee in
Google Scholar
PubMed
Search for other papers by Christopher J Sinal in
Google Scholar
PubMed
Search for other papers by Kathryn Slayter in
Google Scholar
PubMed
Search for other papers by Shelly McNeil in
Google Scholar
PubMed
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada
Search for other papers by Kerry B Goralski in
Google Scholar
PubMed
the right hand column. a A WHR ≥0.85 was used as the cutoff to define central obesity. b A BMI of ≥30 kg/m 2 to define obesity. The estimated glomerular filtration rate (eGFR) was determined from the measured serum creatinine concentration using
Search for other papers by Nannan Bian in
Google Scholar
PubMed
Search for other papers by Xiaomeng Sun in
Google Scholar
PubMed
Search for other papers by Biao Zhou in
Google Scholar
PubMed
Search for other papers by Lin Zhang in
Google Scholar
PubMed
Search for other papers by Qiu Wang in
Google Scholar
PubMed
Search for other papers by Yu An in
Google Scholar
PubMed
Search for other papers by Xiaohui Li in
Google Scholar
PubMed
Search for other papers by Yinhui Li in
Google Scholar
PubMed
Search for other papers by Jia Liu in
Google Scholar
PubMed
Search for other papers by Hua Meng in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
Introduction The morbidity of overweight and obesity has increased globally ( 1 ). During 2013–2014 in the United States, obesity was 40.4% among women and 35% among men. The corresponding incidences for morbid obesity were 9.9% for women and
Search for other papers by Franca Genest in
Google Scholar
PubMed
Search for other papers by Michael Schneider in
Google Scholar
PubMed
Search for other papers by Andreas Zehnder in
Google Scholar
PubMed
Search for other papers by Dominik Lieberoth-Leden in
Google Scholar
PubMed
Search for other papers by Lothar Seefried in
Google Scholar
PubMed
reported to be around 1–2% and 3%, respectively in men >60 years. Furthermore, a combination of sarcopenia with osteoporosis or obesity was assumed to worsen that effect ( 5 , 6 ). The combination of sarcopenia and low BMD reflected in the term
Search for other papers by Eliana Piantanida in
Google Scholar
PubMed
Search for other papers by Daniela Gallo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Giovanni Veronesi in
Google Scholar
PubMed
Search for other papers by Eugenia Dozio in
Google Scholar
PubMed
Search for other papers by Eugenia Trotti in
Google Scholar
PubMed
Search for other papers by Adriana Lai in
Google Scholar
PubMed
Search for other papers by Silvia Ippolito in
Google Scholar
PubMed
Search for other papers by Jessica Sabatino in
Google Scholar
PubMed
Search for other papers by Maria Laura Tanda in
Google Scholar
PubMed
Search for other papers by Antonio Toniolo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Marco Ferrario in
Google Scholar
PubMed
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
calcium along with an increase in adipocyte fatty acid synthase and glycerol-3-phosphate dehydrogenase activities and lipolysis inhibition ( 28 ). Metabolic syndrome (MetS) is a multifactorial condition, having central obesity as a causative factor
Search for other papers by L Bahler in
Google Scholar
PubMed
Search for other papers by H J Verberne in
Google Scholar
PubMed
Search for other papers by E Brakema in
Google Scholar
PubMed
Search for other papers by R Tepaske in
Google Scholar
PubMed
Search for other papers by J Booij in
Google Scholar
PubMed
Search for other papers by J B Hoekstra in
Google Scholar
PubMed
Search for other papers by F Holleman in
Google Scholar
PubMed
. Recently, a quick release variant of bromocriptine has emerged as a new glucose-lowering treatment in obese patients with type 2 diabetes mellitus. Bromocriptine is a centrally acting dopamine D 2 -receptor agonist, but it also weakly stimulates the
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Search for other papers by Kathrin H Popp in
Google Scholar
PubMed
Search for other papers by Gunter Karl Stalla in
Google Scholar
PubMed
prevalence is less clearly established ( 9 ). In a prospective case-control study, the prevalence of ICDs in patients under modest doses of dopaminergic agents was as high as 17% ( 10 ). In patients with prolactinomas, these rare central side effects have
Search for other papers by Devis Pascut in
Google Scholar
PubMed
Search for other papers by Sofia Tamini in
Google Scholar
PubMed
Search for other papers by Silvia Bresolin in
Google Scholar
PubMed
Search for other papers by Pablo Giraudi in
Google Scholar
PubMed
Search for other papers by Giuseppe Basso in
Google Scholar
PubMed
Division of Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Alessandro Minocci in
Google Scholar
PubMed
Search for other papers by Claudio Tiribelli in
Google Scholar
PubMed
Division of Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Graziano Grugni in
Google Scholar
PubMed
Division of Metabolic Diseases, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Division of Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo (VB), Italy
Search for other papers by Alessandro Sartorio in
Google Scholar
PubMed
with obesity had already been proven ( 28 ). In particular, mir-92a-3p negatively correlated with the brown adipose tissue activity ( 29 ), while, the liver-enriched miR-122 was reported to work as central regulator of cholesterol and lipid metabolism
Search for other papers by Katica Bajuk Studen in
Google Scholar
PubMed
Search for other papers by Marija Pfeifer in
Google Scholar
PubMed
( 16 ). Metabolic syndrome Insulin resistance is a central mechanism linking together all components of the metabolic syndrome, defined by the presence of hyperglycemia (fasting glucose levels 5.6 mmol/L or above), central obesity (increased